Hondur Ahmet, Onol Merih, Hasanreisoglu Berati
Dinar State Hospital, Afyonkarahisar, Turkey.
J Glaucoma. 2008 Mar;17(2):139-46. doi: 10.1097/IJG.0b013e31814b98f7.
To evaluate the efficacy of nonpenetrating glaucoma surgery for open angle glaucoma with respect to target intraocular pressure (IOP) and severity of glaucoma.
A literature search with the terms "nonpenetrating glaucoma surgery, deep sclerectomy (DS), viscocanalostomy (VC), and open angle glaucoma" was carried out for the reports in the last 5 years. Studies encompassing only combined glaucoma and cataract surgery were excluded. Measurement of effectiveness was determined on the basis of achievement of target IOP. Data related to postoperative goniopuncture and needling with antimetabolite application were noted.
The percentage of cases achieving <or=21 mm Hg was 48.6% after primary DS, 68.7% after DS with implant, 67.1% after DS with antimetabolite, 51.1% after primary VC, and 36.8% after VC with antimetabolite or implant. Visual field parameters were almost exclusively not available; whereas cup/disk ratio and target IOP lower than 21 mm Hg were available in very few reports. With lower set IOP targets, the rates of success varied between 35% and 86% for DS, and between 10% and 67% for VC. The mean follow-up of the studies were mostly in the range of 3 years.
Nonpenetrating glaucoma surgery seems to provide IOP reduction into the high teens. Its potential to achieve lower target IOPs seems to be low. Longer-term studies, with data related to glaucoma severity and proper target IOPs are required.
评估非穿透性青光眼手术治疗开角型青光眼在目标眼压和青光眼严重程度方面的疗效。
使用“非穿透性青光眼手术、深层巩膜切除术(DS)、粘小管成形术(VC)和开角型青光眼”等术语,对过去5年的报告进行文献检索。仅纳入合并青光眼和白内障手术的研究被排除。根据目标眼压的达成情况来确定疗效。记录与术后前房穿刺及使用抗代谢药物针刺相关的数据。
原发性DS术后眼压≤21 mmHg的病例百分比为48.6%,植入物辅助DS术后为68.7%,抗代谢药物辅助DS术后为67.1%,原发性VC术后为51.1%,抗代谢药物或植入物辅助VC术后为36.8%。几乎没有视野参数数据;而杯盘比和目标眼压低于21 mmHg的数据在极少数报告中可见。设定较低的目标眼压时,DS的成功率在35%至86%之间,VC的成功率在10%至67%之间。这些研究的平均随访时间大多在3年左右。
非穿透性青光眼手术似乎能将眼压降低到十几毫米汞柱的高位。其实现更低目标眼压的潜力似乎较低。需要进行长期研究,并提供与青光眼严重程度和合适目标眼压相关的数据。